Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peikun Pills (培坤丸) is an approved traditional Chinese medicine (TCM) developed and manufactured by Xian Zhengda Pharmaceutical. Formulated as oral small honey pills, it is prepared from a mixture of 22 traditional Chinese herbs, including Astragalus (炙黄芪), Angelica sinensis (酒当归), Rehmannia glutinosa (熟地黄), and others. Peikun Pills are traditionally used to nourish qi and blood, and tonify the liver and kidneys. It is primarily indicated for the treatment of gynecological and reproductive disorders in women, including menstrual disorders, leukorrhea, lower abdominal pain, dyspepsia, and female infertility associated with qi and blood deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Peikun Pills.